Many technologies with the potential to cure disease are advancing rapidly. How long can healthy humans live, 120 years? 150 years? Our portfolio companies are working hard to find out.
Referenced companies reflect current portfolio holdings of OrbiMed-managed private equity funds. There is no assurance that any securities discussed herein are, or will remain, in an OrbiMed-managed portfolio. Any such securities do not represent an entire fund or portfolio and it should not be assumed that they were or will be profitable, or that the investment recommendations or decisions OrbiMed makes in the future will be profitable or will equal the investment performance of such securities. Past performance is not indicative of future results.
Investing with Impact
We seek companies focused on responsible, sustainable growth to build long-term shareholder value, as outlined in our Responsible Investing Policy.
Delivering New Cures
Over 60 new healthcare therapies have been successfully developed and brought to patients by OrbiMed’s private portfolio companies.Solving the Greatest Needs
OrbiMed has committed nearly $2 billion to improve developing-country healthcare, from maternal care hospitals in India to dialysis centers in China.Starting New Companies
OrbiMed has backed over 90 life sciences start-ups, pushing the boundaries of medicine to achieve breakthroughs for patients.Making a Difference
Through a charitable matching program and paid time off for community service, we empower team members to become positive changemakers in their communities.
OrbiMed’s team and portfolio companies are striving to improve healthcare quality, access and affordability for patients around the globe.